Inhibitory effect of a novel resveratrol derivative on nitric oxide production in lipopolysaccharide-activated microglia

Pharmazie

Volumn 63, Issue 9, 2008, Pages 671-675

  Meng, X L ^a   Chen, G L ^a   Yang, J Y ^a   Wang, S ^a   Wu, Chun Fu ^a   Wang, J M ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 (3 NITROSTYRYL)BENZENE 1,3 DIOL; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RESVERATROL; RV 06; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; MICROGLIA; NEWBORN; NONHUMAN; RAT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; FREE RADICAL SCAVENGERS; HUMANS; INDICATORS AND REAGENTS; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; NITROPRUSSIDE; REACTIVE NITROGEN SPECIES; STILBENES;

EID: 52649105485     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8553     Document Type: Article

References (27)

1. Anekonda TS (2006) Resveratrol - A boon for treating Alzheimer's disease? Brain Res Rev 52: 316-326.
2. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878-881.
3. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshimad T, Zhao YQ, Wu CF (2005) Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia. Int Immunopharmacol 5: 185-193.
4. Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188.
5. Bureau G, Longpré F, Martinoli MG (2008) Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 86: 403-410.
6. Candelario-Jalil E, de Oliveira AC, Gräf S, Bhatia HS, Hüll M, Muñoz E, Fiebich BL (2007) Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation 4: 25.
7. Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D (2000) Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60: 1539-1548.
8. Chang JY, Chavis JA, Liu LZ, Drew PD (1998) Cholesterol oxides induce programmed cell death in microglial cells. Biochem Biophys Res Commun 249: 817-821.
9. Chen G, Shan W, Wu Y, Ren L, Dong J, Ji Z (2005) Synthesis and antiinflammatory activity of resveratrol analogs. Chem Pharm Bull 53: 1587-1590.
10. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83.
11. Goldberg DM, Ng E, Karumanchiri A, Yan J, Diamandis EP, Soleas GJ (1995) Assay of resveratrol glucosides and isomers in wine by direct-injection high-performance liquid chromatography. J Chromatogr 708: 984-989.
12. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219-240.
13. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
14. Jeandet P, Bessis R, Maume BF, Meunier P, Peyron D, Trollat P (1995) Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem 43: 316-319.
15. Kim YA, Kim GY, Park KY, Choi YH (2007) Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J Med Food 10: 218-224.
16. Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TF (2003) Oxy-resveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 9: 64-76.
17. Marcocci L, Maguire JJ, Droy-Lefaiz MT, Packer L (1994) The nitric oxide-scavenging properties of Ginkgo biloba extract EGB 761. Biochem Biophys Res Commun 201: 748-755.
18. Mcgeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7: 84-92.
19. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by β-amyloid protein and IFN-γ. Nature 373: 647-650.
20. 24. Nitric Oxide 11: 201-207.
21. Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A (2007) Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 73: 550-560.
22. Possel H, Noack H, Putzke J, Wolf G, Sies H (2000) Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32: 51-59.
23. Schroeder RA, Kuo PC (1995) Nitric oxide: physiology and pharmacology. Anesth Analg 81: 1052-1059.
24. Trela BC, Waterhouse AL (1996) Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 44: 1253-1257.
25. Tzeng SF, Huang HY (2003) Downregulation of inducible nitric oxide synthetase by neurotrophin-3 in microglia. J Cell Biochem 90: 227-233.
26. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958: 439-447.
27. Yen G, Lai H, Chou H (2001) Nitric oxide-scavenging and antioxidant effects of Uraria crinita root. Food Chem 74: 471-478.